Why systems beat metrics in life sciences with Gabriel Morelli

The Leadership Shift From Scientist to CEO in Biotech With Abbie Celniker

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Abbie Celniker [https://www.linkedin.com/in/abbie-celniker-277a356/], Partner at Third Rock Ventures. Abbie Celniker has spent four decades in the life sciences, from early scientific roles at Genentech to Chief Executive Officer (CEO) positions at Taliesin and 11 Biotherapeutics, and now as a partner at Third Rock Ventures, creating and developing new biotech companies. In this conversation, she shares what it means to be a biotech pioneer, why the CEO should act as an emcee (master of ceremonies), and how patient urgency shaped the first generation of company builders. She also covers investor-operator dynamics and what the next generation of leaders will need to succeed. Click or tap the play button to watch the video or tune in on Spotify, Apple Podcasts or Amazon Music. Key Takeaways * Learn why authenticity and trust are practical foundations of biotech leadership, not soft skills, and how they hold high-risk teams together when the science becomes uncertain. * Discover how patient urgency drove the first generation of biotech builders, and what that mission-driven instinct means when creating new life science companies today. * Understand the CEO-as-emcee principle: how surrounding yourself with domain experts and stepping back from the spotlight creates stronger results across every function. * Explore why letting go of execution is a requirement at senior level, and how staying too close to the data holds your team and your organisation back. * Gain insight into what an integrated leadership team looks like at each company stage, and how to stop internal competition from undermining collective decision-making. * Identify the tension between investor and operator perspectives on boards, and why balancing those viewpoints leads to better scientific and strategic decisions. * Take away practical advice for stepping into senior leadership before you have all the experience: why your executive team must act as thought partners, not simply direct reports. Snippets * "All of a sudden, you don't have any real line oversight of the people who are doing the work for you. You have to lead by influence, and you need to get things done." * "I want every single person I hire to know more than I do. I want them to be more expert in every area... I just want them to be superstars." * "If they're constantly so out looking to grab the spotlight, they're going to potentially be missing opportunities to be motivating some of the superstars that can actually deliver the goods." Timestamps & Topics The following timestamps are approximations: * [00:00] – Intro: Abbie Celniker’s four-decade career across biotech and life sciences * [01:30] – Active Ingredients: Authenticity, trust, and culture as leadership foundations * [07:35] – Career Start: Joining Genentech in 1986 and the power of cross-functional project teams * [16:38] – Biotech Pioneers: How patient urgency defined the first generation of company builders * [29:09] – Letting Go: Why moving from execution to leadership is a requirement, not a choice * [37:25] – CEO as Emcee: Leading through experts rather than being the expert in the room * [45:41] – Boards and Investors: Navigating operator-investor tension at board level Resources * Follow Abbie Celniker on LinkedIn: https://www.linkedin.com/in/abbie-celniker-277a356/ [https://www.linkedin.com/in/abbie-celniker-277a356/] * Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ [https://www.linkedin.com/in/lifesciencesexecutivesearch/] Don't Miss an Episode Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠⁠⁠ [https://fraserdove.com/active-ingredients-life-science-leadership-podcast/]. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠ [https://podcasts.apple.com/us/podcast/active-ingredients/id1807042435], ⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠ [https://music.amazon.co.uk/podcasts/71cb7e61-ae0c-43c5-83b2-d179651a058f/active-ingredients], ⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠ [https://open.spotify.com/show/1KjY518XLwRXz9vDAls8Sc], ⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.youtube.com/@fraserdoveint] and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!

Values, Courage and Transformation in Life Sciences with Paula Gildert

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Paula Gildert, Strategic Advisor & Board Member, Xyant Services. Paula Gildert is a procurement and transformation leader who has worked across AstraZeneca, Novartis and Takeda. She served as President and Chair of the Chartered Institute of Procurement and Supply (CIPS) and now advises life sciences organisations on strategy and governance. Paula reveals how values, courage, and commitment fuel her leadership style. She shares frameworks for breakthrough thinking, champions speed and quality over pure cost, and vividly describes her journey from corporate executive to board advisor. Key Takeaways * Experience how courage, authenticity, and commitment ignite leadership and help senior leaders build trust across the pharmaceutical landscape. * See why “context is decisive” in transformation. Gildert shows how reading your team’s environment sets every strategy in motion. * Unlock how breakthrough thinking turns stretch goals into tangible results by zeroing in on what’s missing and boldly making clear promises. * Discover how speed and quality ignite value creation in procurement and watch cost savings flow naturally as business processes evolve. * Gain practical advice on keeping teams energised during multi-year change by celebrating progress and keeping senior leadership visibly engaged. * Identify how communication training gives leaders a lasting edge. Gildert explains why structured frameworks for conversations pay dividends across every setting. * Explore how a Royal Marine upbringing shaped Gildert’s early leadership. She traces her resilience, her ability to hold her ground and her openness to being wrong back to her father’s influence. * Sharpen your listening and curiosity as a young leader. Gildert shares how face-to-face conversations and focus groups shape strategy from the ground up. * Use Gildert’s “third chapter” story as inspiration to shape your own vibrant move from executive to impactful advisory, board and voluntary roles. Snippets * Business is mostly bad news with a spattering of good. If you’re in a high change environment, it’s not a balance.” * “Once you work in the pharmaceutical industry, and you’re driven by a higher purpose, everything else will pale in comparison.” * “Oftentimes, you have the team you need. You just haven’t rallied them around the right challenge.” Timestamps & Topics The following timestamps are approximations: * [00:00] – Intro: Paula Gildert’s leadership journey in the life sciences * [01:37] – Key Ingredients: Values, authenticity and commitment * [03:51] – Early Influences: Growing up with Royal Marine leadership * [16:29] – Delivering Impact: Inspiring teams through large-scale change * [23:12] – Value Creation: Why speed and quality beat cost in procurement * [27:03] – Breakthrough Thinking: Turning stretch goals into real results * [34:30] – Emotional Intelligence: Leading when values don’t align * [46:09] – Third Chapter: Leadership beyond the corporate org chart * [56:50] – Future of Life Sciences: Access, affordability and new technology Resources * Follow Paula Gildert on LinkedIn: https://www.linkedin.com/in/paula-gildert-547b987/ [https://www.linkedin.com/in/paula-gildert-547b987/]• * Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ [https://www.linkedin.com/in/lifesciencesexecutivesearch/] Don't Miss an Episode Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠⁠ [https://fraserdove.com/active-ingredients-life-science-leadership-podcast/]. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠ [https://podcasts.apple.com/us/podcast/active-ingredients/id1807042435], ⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠ [https://music.amazon.co.uk/podcasts/71cb7e61-ae0c-43c5-83b2-d179651a058f/active-ingredients], ⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠ [https://open.spotify.com/show/1KjY518XLwRXz9vDAls8Sc], ⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠ [https://www.youtube.com/@fraserdoveint] and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!

Commercial Leadership In Pharma With Gaurav Jain

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gaurav Jain, Chief Commercial Officer (CCO) at Modavar Pharmaceuticals LLC. Gaurav Jain is a globally experienced commercial leader with over 22 years in the pharmaceutical industry. He has led business development and mergers and acquisitions (M&A) across branded generics, orphan drugs, and multinational companies in markets spanning Asia, the United States, and beyond. In this conversation, Gaurav explains how he entered the industry by chance and built his career by setting clear goals, staying adaptable, and taking on challenges beyond his experience. He also shares how pharma deal structures have shifted away from large upfront payments toward models in which both partners share risk based on a product's performance. He also discusses how senior leaders can protect their organisations from the disruption caused by rising trade barriers and global supply chain instability.  Key Takeaways * Learn why clear objective setting forms the foundation of effective leadership in pharmaceutical organisations, and how defining deliverables from day one gives teams direction and prevents wasted effort. * Discover how Gaurav Jain's career path from banking into branded generics and M&A shows that subject matter expertise matters less than the ability to work with experts and ask the right questions. * Understand how to build high-performing commercial teams by hiring for motivation and mindset rather than industry knowledge alone, and why open dialogue leads to stronger business outcomes. * Explore how performance-based deal structures have replaced front-loaded payments in pharmaceutical partnerships, and why shared risk now underpins long-term commercial relationships of all sizes. * Identify the steps senior leaders should take to protect their organisations from rising global trade barriers, including diversifying supply chains, monitoring P&L exposure, and engaging proactively with policymakers. Snippets *  "You don't need to be an expert in every space. What you need to know is how experts perform in their own space, and how to work with the experts to learn enough to work along with the greater organisation." * "Even after you close the deal, it's not the end. It's kind of a beginning of another major set of challenges... You might have a great idea, but if you don't really follow up on those ideas during integration, you kind of lose value." * "A lot of times I've seen industry professionals look at AI as something that can just shorten the amount of thinking they need to do. AI is not a substitute to strategy, to vision, to thinking, to a challenge." Timestamps & Topics The following timestamps are approximations: * [00:29] Key Ingredients: Objective setting, adaptability and strategic planning * [00:31] Career Path: From banking into the pharmaceutical industry * [00:47] Deal Making: What makes M&A a genuine breakthrough for an organisation * [00:54] Partnership Evolution: How deal structures have shifted to performance-based models * [00:59] Trade Barriers: Navigating geopolitical disruption and supply chain risk * [01:07] Future of Leadership: AI, data and the next generation of life sciences leaders Resources * Follow Gaurav Jain on LinkedIn: https://www.linkedin.com/in/gaurav-jain-032b9417/ [https://www.linkedin.com/in/gaurav-jain-032b9417/] * ResourcesFollow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ [https://www.linkedin.com/in/lifesciencesexecutivesearch/] Don't Miss an Episode Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠ [https://fraserdove.com/active-ingredients-life-science-leadership-podcast/]. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠ [https://podcasts.apple.com/us/podcast/active-ingredients/id1807042435], ⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠ [https://music.amazon.co.uk/podcasts/71cb7e61-ae0c-43c5-83b2-d179651a058f/active-ingredients], ⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠ [https://open.spotify.com/show/1KjY518XLwRXz9vDAls8Sc], ⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠ [https://www.youtube.com/@fraserdoveint] and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!

Why systems beat metrics in life sciences with Gabriel Morelli

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gabriel Morelli, Global Freelance Consultant, Advisor and Certified Mentor and Coach. Gabriel Morelli has spent over 25 years in life sciences, spanning generics, CDMOs, consulting and private equity-backed organisations. His career began in Montevideo, was redirected by a British Council scholarship MBA at Cranfield, and has since evolved into an independent advisory practice across the pharma value chain. In this conversation, he explains why most generics and CDMO companies chase the wrong metrics, how to assess a new role within 90 days, and why the freelance leap demands more preparation than most executives expect. Key Takeaways • Learn why integrity, curiosity and genuine interest in people are Gabriel's three non-negotiable leadership qualities, shaped across generics, CDMOs and private equity. • Discover how the systemic view of commercial excellence separates strong generics and CDMO businesses from those that optimise one element while quietly failing everywhere else. • Understand why private equity operates by different rules from corporate life, and why more than half of senior hires struggle once the armies of support are gone. • Explore Gabriel's 90-day rule for assessing whether you can succeed in a new role, and why acting on an honest answer early signals clarity rather than weakness. • Apply the planning principles behind a credible freelance advisory career: a defined niche, consulting skills and commercial fitness before leaving corporate employment. • Gain a clearer view of idea diversity and why teams built around genuine intellectual friction produce stronger outcomes than diversity defined by demographics alone. • Identify why the value most senior executives believe they carry is tied to their company and title, and why most discover this too late to act. • Uncover how Gabriel grew from 5,000 to 22,000 LinkedIn followers through daily publishing, and why a consistent point of view wins more advisory work than any CV. • Take away why adaptability will define the next generation of life science leaders as geopolitics, technology and talent continue to accelerate. Snippets • “The moment you feel that you will not be successful, just push the eject button, disappear, and, focus on something else.” • “It doesn’t really matter if you do something great downstream. If upstream, you’re doing everything wrong… it’s better to do everything average than to be great at KPIs.” • “I’m not so fixated on the diversity, equity and inclusion… To me, what is important is, is ideas… You want people with different ideas with some tensions, some friction, but it needs to be operational.” Timestamps & Topics The following timestamps are approximations: • [00:00] –– Intro: Gabriel Morelli’s career across generics, CDMOs, consulting and private equity • [04:14] –– Career Origins: From Montevideo to Cranfield and the MBA that led to life sciences • [18:47] –– Commercial Strategy: The systemic gap in commercial excellence across generics and CDMOs • [21:59] –– Private Equity: Cash discipline, no place to hide, and why most corporate hires struggle • [29:20] –– Quit Fast: The 90-day rule and why staying for appearances is the wrong move • [35:29] –– Second Wave: Defining a niche and why LinkedIn replaces traditional business development Resources • Follow Gabriel Morelli on LinkedIn: https://www.linkedin.com/in/morelligabriel/ [https://www.linkedin.com/in/morelligabriel/] • Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ [https://www.linkedin.com/in/lifesciencesexecutivesearch/] Don't Miss an Episode Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠ [https://fraserdove.com/active-ingredients-life-science-leadership-podcast/]. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠ [https://podcasts.apple.com/us/podcast/active-ingredients/id1807042435], ⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠ [https://music.amazon.co.uk/podcasts/71cb7e61-ae0c-43c5-83b2-d179651a058f/active-ingredients], ⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠ [https://open.spotify.com/show/1KjY518XLwRXz9vDAls8Sc], ⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠ [https://www.youtube.com/@fraserdoveint] and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!

From Site Head to Global Leader in Pharma Manufacturing With Laura O'Brien

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Laura O'Brien, Global Operations and Quality Executive. Laura O'Brien is one of the most experienced operations and quality leaders in pharma manufacturing, having held VP and SVP roles at Sanofi, Novartis and CSL across four site head roles in the UK and beyond. In this conversation, she shares what it means to be the first female leader on a manufacturing site, how to build and retain world-class teams, and why shifting from direct control to influence is a defining challenge for global pharma leaders.   Key Takeaways • Learn why Laura O'Brien's three leadership ingredients (authentic, bold, and connected) are daily disciplines tested by the pressures of senior pharma leadership, not abstract values on a wall. • Discover how mentors become sponsors, and why the most career-defining moments come from being placed in roles you never felt ready for. • Understand why the site head role is the single most important step in a manufacturing leader's career, blending total site accountability with board-level visibility. • Explore how to make the shift from direct control at site level to leading by influence across a global network of pharma manufacturing sites. • Apply Laura's hiring framework: going beyond competency-based interviews to find candidates who will genuinely transform the organisation at this specific point in time. • Gain a new perspective on the number one team concept, and why your strongest professional loyalty should sit with your peer group rather than the team you directly manage. • Uncover what walking the talk really demands from a senior leader, and why authentic role modelling is the only reliable way to build lasting organisational alignment. • Take away Laura's advice on balancing a demanding pharma career with family life, and why trading off rather than trying to do everything perfectly is the smarter long-term strategy. • Identify the difference between a mentor and a sponsor, and why true sponsorship means advocating for someone at board level, not just offering guidance.   Snippets • "People will not align behind you if they don't see that you believe in it and [that] you're engaged in it too." • "Don't try to be perfect. In my view, it's impossible if you really want to do all of these things really well. So trade off one against the other at different times." • "Surround yourself with the best people... what I'm really looking for is: is this person going to transform the organisation in the way it needs to be transformed at this point in time?"   Timestamps & Topics The following timestamps are approximations:   • [05:20] -- Intro: Laura O'Brien's background in global pharma operations and quality • [06:48] -- Active Ingredients: Authentic, bold, and connected as the pillars of leadership • [10:24] -- Career Origins: From pharmacy school to a purposeful industrial pharma career • [17:20] -- Site Head: The role that shaped Laura's leadership, including being the first female site head • [26:16] -- Team Building: Hiring for transformation, not just competency • [38:33] -- Global Leadership: Shifting from direct control to influence across a network • [57:54] -- Future of Pharma: AI, patients, and the leadership qualities that will always matter   Resources • Follow Laura O'Brien on LinkedIn: https://www.linkedin.com/in/laura-o-brien-4556557/ [https://www.linkedin.com/in/laura-o-brien-4556557/] Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ [https://www.linkedin.com/in/lifesciencesexecutivesearch/] Don't Miss an Episode Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠ [https://fraserdove.com/active-ingredients-life-science-leadership-podcast/]. Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠ [https://podcasts.apple.com/us/podcast/active-ingredients/id1807042435], ⁠⁠⁠⁠Amazon⁠⁠⁠⁠ [https://music.amazon.co.uk/podcasts/71cb7e61-ae0c-43c5-83b2-d179651a058f/active-ingredients], ⁠⁠⁠⁠Spotify⁠⁠⁠⁠ [https://open.spotify.com/show/1KjY518XLwRXz9vDAls8Sc], ⁠⁠⁠⁠YouTube⁠⁠⁠⁠ [https://www.youtube.com/@fraserdoveint] and other leading podcast platforms. Loved this episode? Share it with your friends, family, or your peers!